Zamanillo, I.; Medina de Alba, L.; Gil, R.; de la Puerta, R.; Alonso, R.; Jimenez-Ubieto, A.; Cedena, M.T.; Calbacho, M.; Ayala, R.; Martinez-Lopez, J.
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure. Life 2023, 13, 1841.
https://doi.org/10.3390/life13091841
AMA Style
Zamanillo I, Medina de Alba L, Gil R, de la Puerta R, Alonso R, Jimenez-Ubieto A, Cedena MT, Calbacho M, Ayala R, Martinez-Lopez J.
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure. Life. 2023; 13(9):1841.
https://doi.org/10.3390/life13091841
Chicago/Turabian Style
Zamanillo, Irene, Lucia Medina de Alba, Rodrigo Gil, Rosalia de la Puerta, Rafael Alonso, Ana Jimenez-Ubieto, Maria Teresa Cedena, Maria Calbacho, Rosa Ayala, and Joaquin Martinez-Lopez.
2023. "Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure" Life 13, no. 9: 1841.
https://doi.org/10.3390/life13091841
APA Style
Zamanillo, I., Medina de Alba, L., Gil, R., de la Puerta, R., Alonso, R., Jimenez-Ubieto, A., Cedena, M. T., Calbacho, M., Ayala, R., & Martinez-Lopez, J.
(2023). Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure. Life, 13(9), 1841.
https://doi.org/10.3390/life13091841